0
0
Read Time:6 Second
Alembic Pharmaceuticals Limited has informed the Exchange regarding ‘Alembic Pharmaceuticals receives USFDA Final Approval for Doxorubicin Hydrochloride Liposome Injection’. |SUBJECT: Updates
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %